Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

E-PILO 4 OPHTHALMIC SOLUTION 10 MG

EPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 40 MG · DIN 02133202 · CIBA VISION CANADA INC

Health Canada status: CANCELLED POST MARKET

What is E-PILO 4 OPHTHALMIC SOLUTION?

E-PILO 4 OPHTHALMIC SOLUTION 10 MG contains EPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02133202, held by CIBA VISION CANADA INC, supplied as DROPS for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 13-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02133202
Brand nameE-PILO 4 OPHTHALMIC SOLUTION
Generic / active ingredientEPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 40 MG
ManufacturerCIBA VISION CANADA INC
Strength10 MG
Dosage formDROPS
Route of administrationOPHTHALMIC
SchedulePrescription
ATC codeS01EB51 PILOCARPINE, COMBINATIONS
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date13-Jul-1999

What can be used instead?

Other Canadian products sharing ATC code S01EB51 PILOCARPINE, COMBINATIONS. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
E-PILO 1 OPHTHALMIC SOLUTION10 MGDROPSCIBA VISION CANADA INCCANCELLED POST MARKETDIN 02133180
E-PILO 2 OPHTHALMIC SOLUTION20 MGDROPSCIBA VISION CANADA INCCANCELLED POST MARKETDIN 02133199
E-PILO 6 OPHTHALMIC SOLUTION10 MGDROPSCIBA VISION CANADA INCCANCELLED POST MARKETDIN 02133210
E-PILO-1 OPH SOLN10 MGDROPSIOLAB PHARMACEUTICALSCANCELLED POST MARKETDIN 00760021
E-PILO-2 OPH SOLN10 MGDROPSIOLAB PHARMACEUTICALSCANCELLED POST MARKETDIN 00759996
E-PILO-4 OPH SOLN10 MGDROPSIOLAB PHARMACEUTICALSCANCELLED POST MARKETDIN 00760013
E-PILO-6 OPH SOLN60 MGDROPSIOLAB PHARMACEUTICALSCANCELLED POST MARKETDIN 00760005

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for E-PILO 4 OPHTHALMIC SOLUTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for E-PILO 4 OPHTHALMIC SOLUTION

Health Canada Drug Product Database (DPD), DIN 02133202. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.